[Death from malignant hyperthermia. Etiology, pathophysiology, epidemiology and pathomorphology].
D000255:Adenosine Triphosphate / Q000378:metabolism; D000293:Adolescent; D000311:Adrenal Glands / Q000473:pathology; D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D001921:Brain / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D002675:Child, Preschool; D005260:Female; D005334:Fever / Q000401:mortality*; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009132:Muscles / Q000002:abnormalities; D009135:Muscular Diseases / Q000150:complications / Q000235:genetics; D009206:Myocardium / Q000473:pathology; D012508:Sarcolemma / Q000378:metabolism; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D013154:Spleen / Q000473:pathology; D013390:Succinylcholine / Q000009:adverse effects; D013950:Thymus Gland / Q000473:pathology
D008996:Monoamine Oxidase Inhibitors; D000255:Adenosine Triphosphate; D013390:Succinylcholine; D002118:Calcium; D006221:Halothane
Tod durch maligne Hyperthermie.